{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:01:15Z","timestamp":1790841675992,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.clim.2022.109027","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:46:46Z","timestamp":1651492006000},"page":"109027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["SARS-CoV-2\/COVID-19 and its relationship with NOD2 and ubiquitination"],"prefix":"10.1016","volume":"238","author":[{"given":"Edgardo Guzman","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joann","family":"Salvemini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lozeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.clim.2022.109027_bb0005","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.3390\/ijms21155513","article-title":"Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.clim.2022.109027_bb0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nri2436","article-title":"Viral evasion and subversion of pattern-recognition receptor signalling","volume":"8","author":"Bowie","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"6515","key":"10.1016\/j.clim.2022.109027_bb0015","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"7889","key":"10.1016\/j.clim.2022.109027_bb0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","article-title":"Mapping the human genetic architecture of COVID-19","volume":"600","author":"Initiative","year":"2021","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.clim.2022.109027_bb0025","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/STROKEAHA.120.030365","article-title":"Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China","volume":"51","author":"Qin","year":"2020","journal-title":"Stroke."},{"issue":"8","key":"10.1016\/j.clim.2022.109027_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/v13081490","article-title":"Detection of IFNgamma-Secreting CD4(+) and CD8(+) memory T Cells in COVID-19 convalescents after stimulation of peripheral blood mononuclear cells with Live SARS-CoV-2","volume":"13","author":"Matyushenko","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.clim.2022.109027_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa2102605","article-title":"Multisystem inflammatory syndrome in children - initial therapy and outcomes","volume":"385","author":"Son","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.clim.2022.109027_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021570","article-title":"Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: a case report","volume":"99","author":"Lolachi","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"10.1016\/j.clim.2022.109027_bb0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.clim.2022.109027_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2022.109027_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(21)00218-6","article-title":"Adult-onset Still\u2019s disease following COVID-19 vaccination","volume":"3","author":"Leone","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.clim.2022.109027_bb0060","doi-asserted-by":"crossref","first-page":"108878","DOI":"10.1016\/j.clim.2021.108878","article-title":"Adult-onset Still\u2019s disease following mRNA COVID-19 vaccination","volume":"233","author":"Sharabi","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2022.109027_bb0065","first-page":"1","article-title":"New-onset Adult-onset Still\u2019s disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature","author":"Padiyar","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2022.109027_bb0070","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-021-24285-4","article-title":"COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants","volume":"12","author":"Jalkanen","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.clim.2022.109027_bb0075","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/vaccines9080848","article-title":"Antigen presentation of mRNA-based and virus-vectored SARS-CoV-2 vaccines","volume":"9","author":"Rijkers","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.clim.2022.109027_bb0080","first-page":"Jiab593","article-title":"Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines","author":"Naranbhai","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.clim.2022.109027_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ane.13575","article-title":"Baleeiro Rodrigues Silva P, Freitas Barboza IC, Vieira Silveira CG, et al. Guillain-Barre syndrome following COVID-19 vaccines: a scoping review","volume":"145","author":"Lahoz Fernandez","year":"2021","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/j.clim.2022.109027_bb0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MOP.0000000000001061","article-title":"Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children","volume":"33","author":"Schulert","year":"2021","journal-title":"Curr. Opin. Pediatr."},{"issue":"6837","key":"10.1016\/j.clim.2022.109027_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.clim.2022.109027_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semarthrit.2012.12.005","article-title":"Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases","volume":"43","author":"Yao","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2022.109027_bb0105","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar3462","article-title":"A new category of autoinflammatory disease associated with NOD2 gene mutations","volume":"13","author":"Yao","year":"2011","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"10.1016\/j.clim.2022.109027_bb0110","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2012.09.025","article-title":"Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations","volume":"68","author":"Yao","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.clim.2022.109027_bb0115","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/rheumatology\/kev207","article-title":"NOD2-associated autoinflammatory disease: a large cohort study","volume":"54","author":"Yao","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.clim.2022.109027_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2016.09.028","article-title":"A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease","volume":"130","author":"Yao","year":"2017","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.clim.2022.109027_bb0125","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/rheumatology\/ket143","article-title":"Distal lower extremity swelling as a prominent phenotype of NOD2-associated autoinflammatory disease","volume":"52","author":"Yao","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clim.2022.109027_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/RHU.0000000000000468","article-title":"Case of NOD2-associated autoinflammatory disease successfully treated with sulfasalazine","volume":"23","author":"Estephan","year":"2017","journal-title":"J. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2022.109027_bb0135","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1097\/RHU.0000000000001655","article-title":"Expansion of phenotypic and genotypic Spectrum in Yao syndrome: a case series","volume":"28","author":"Yao","year":"2020","journal-title":"J. Clin. Rheumatol."},{"issue":"19","key":"10.1016\/j.clim.2022.109027_bb0140","first-page":"32757","article-title":"Research letter: effectiveness of canakinumab for the treatment of Yao syndrome patients","volume":"S0190\u20139622","author":"Yao","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.clim.2022.109027_bb0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nrm3982","article-title":"The unravelling of the ubiquitin system","volume":"16","author":"Ciechanover","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.clim.2022.109027_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tibs.2019.01.011","article-title":"Using ubiquitin binders to decipher the ubiquitin code","volume":"44","author":"Mattern","year":"2019","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.clim.2022.109027_bb0155","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"issue":"27","key":"10.1016\/j.clim.2022.109027_bb0160","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109027_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17924","article-title":"The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico-histopathologic presentation","author":"Khosravi-Hafshejani","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"11","key":"10.1016\/j.clim.2022.109027_bb0170","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome","volume":"157","author":"Zakine","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"16","key":"10.1016\/j.clim.2022.109027_bb0175","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.clim.2022.109027_bb0180","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing Polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.clim.2022.109027_bb0185","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","article-title":"Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience","volume":"6","author":"Diarra","year":"2022","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.clim.2022.109027_bb0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.clim.2022.109027_bb0195","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","article-title":"Activation of innate immune antiviral responses by Nod2","volume":"10","author":"Sabbah","year":"2009","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2022.109027_bb0200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.it.2017.07.004","article-title":"NOD1 and NOD2: beyond peptidoglycan sensing","volume":"38","author":"Keestra-Gounder","year":"2017","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.clim.2022.109027_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00491-21","article-title":"Nodosome inhibition as a novel broad-Spectrum antiviral strategy against arboviruses, enteroviruses, and SARS-CoV-2","volume":"65","author":"Limonta","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.clim.2022.109027_bb0210","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/ijlh.13717","article-title":"New insights into genetic characteristics between multiple myeloma and COVID-19: an integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data","volume":"43","author":"Wang","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"5","key":"10.1016\/j.clim.2022.109027_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036734","article-title":"Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection","volume":"7","author":"Coulombe","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clim.2022.109027_bb0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2022.109027_bb0225","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fimmu.2017.00644","article-title":"Whole blood profiling of Bacillus Calmette-Guerin-induced trained innate immunity in infants identifies epidermal growth factor, IL-6, platelet-derived growth factor-AB\/BB, and natural killer cell activation","volume":"8","author":"Smith","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.109027_bb0230","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1189\/jlb.4MA0215-059R","article-title":"Long-term in vitro and in vivo effects of gamma-irradiated BCG on innate and adaptive immunity","volume":"98","author":"Arts","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.clim.2022.109027_bb0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14760584.2021.1938550","article-title":"COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials","volume":"20","author":"Gong","year":"2021","journal-title":"Expert Rev Vaccines."},{"issue":"6","key":"10.1016\/j.clim.2022.109027_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/ajhb.23504","article-title":"SARS-CoV-2 infection in India bucks the trend: trained innate immunity?","volume":"33","author":"Chinnaswamy","year":"2021","journal-title":"Am. J. Hum. Biol."},{"issue":"10","key":"10.1016\/j.clim.2022.109027_bb0245","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.3390\/ijms21103492","article-title":"Deubiquitinating enzymes in coronaviruses and possible therapeutic opportunities for COVID-19","volume":"21","author":"Clemente","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.clim.2022.109027_bb0250","doi-asserted-by":"crossref","first-page":"109754","DOI":"10.1016\/j.celrep.2021.109754","article-title":"A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease","volume":"36","author":"Patchett","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2022.109027_bb0255","doi-asserted-by":"crossref","first-page":"102644","DOI":"10.1016\/j.jaut.2021.102644","article-title":"An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19","volume":"120","author":"Wang","year":"2021","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.clim.2022.109027_bb0260","doi-asserted-by":"crossref","first-page":"a036426","DOI":"10.1101\/cshperspect.a036426","article-title":"Regulation of cell death and immunity by XIAP","volume":"12","author":"Jost","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.clim.2022.109027_bb0265","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1074\/jbc.M112.413781","article-title":"Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2","volume":"288","author":"Ver Heul","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.clim.2022.109027_bb0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ni.2892","article-title":"Immune diseases caused by mutations in kinases and components of the ubiquitin system","volume":"15","author":"Cohen","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2022.109027_bb0275","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3389\/fimmu.2019.02648","article-title":"The ubiquitin code of NODs signaling pathways in health and disease","volume":"10","author":"Martinez-Torres","year":"2019","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.clim.2022.109027_bb0280","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145472","article-title":"Ubiquitination of ATF6 by disease-associated RNF186 promotes the innate receptor-induced unfolded protein response","volume":"131","author":"Ranjan","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clim.2022.109027_bb0285","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ni.2563","article-title":"Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection","volume":"14","author":"Lupfer","year":"2013","journal-title":"Nat. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:07:04Z","timestamp":1761494824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":57,"alternative-id":["S1521661622001085"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109027","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2\/COVID-19 and its relationship with NOD2 and ubiquitination","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109027"}}